U.S. Tobacco Stock News

NasdaqGS:HSIC
NasdaqGS:HSICHealthcare

Henry Schein Sales Surge And CEO Stock Sale Refocus Investor Attention

Henry Schein (NasdaqGS:HSIC) reported its strongest sales growth in 15 quarters, highlighting a shift in recent operating momentum. The company introduced a new multi year value creation plan that outlines its priorities for the coming years. A large stock sale by the CEO followed these announcements, drawing attention to insider activity at the company. Henry Schein enters this news cycle with its shares at $80.17 and a value score of 5, reflecting how the market has been pricing the...
NYSE:XYL
NYSE:XYLMachinery

Assessing Xylem (XYL) Valuation After A New US$1.5b Share Buyback Authorization

New Xylem buyback plan and what it could mean for shareholders Xylem (XYL) has authorized a new share repurchase program of up to US$1.5b with no expiration date, prompting fresh questions about how this move might affect valuation, capital allocation, and long term shareholder returns. See our latest analysis for Xylem. The new buyback comes at a time when Xylem’s share price has eased, with a 30 day share price return of an 8.93% decline and a year to date share price return of a 7.96%...
NYSE:LUMN
NYSE:LUMNTelecom

Is It Time To Reassess Lumen Technologies (LUMN) After Recent Price Volatility?

If you are wondering whether Lumen Technologies at US$6.83 is a bargain or a value trap, you are in the right place as we unpack what the current price really implies. The stock has been volatile, with a 3% decline over the last 7 days, a 19.3% decline over the last 30 days, an 11.2% decline year to date and a 35.8% return over the last year. Recent attention on Lumen has included ongoing discussions about its debt load, refinancing efforts and long term business transformation plans. These...
NasdaqGS:AMBA
NasdaqGS:AMBASemiconductor

Ambarella (AMBA) Is Down 21.8% After Guiding to FY 2027 Revenue Growth of 10%–15%

In late February 2026, Ambarella, Inc. reported fourth-quarter sales of US$100.87 million and a net loss of US$16.44 million, alongside full-year sales of US$390.70 million and a reduced annual net loss of US$75.87 million compared with the prior year. Management also issued revenue guidance of US$97.00 million to US$103.00 million for the first quarter of fiscal 2027 and projected total revenue growth of 10% to 15% for fiscal 2027, underscoring ongoing demand for its Edge-AI system-on-chip...
NYSE:SCCO
NYSE:SCCOMetals and Mining

Strait Of Hormuz Closure Puts Southern Copper Costs And Valuation In Focus

Military conflict in the Middle East has led to the closure of the Strait of Hormuz, disrupting a key global energy and shipping route. This chokepoint closure is creating volatility across mining and metals companies, including Southern Copper (NYSE:SCCO), as fuel supply and transport risks rise. Investors are watching how higher energy costs and logistical challenges could affect operating expenses and margins for producers such as Southern Copper. Southern Copper, listed as NYSE:SCCO, is...
NasdaqCM:LMB
NasdaqCM:LMBConstruction

Is Limbach Holdings (LMB) Still Attractive After Recent Share Price Pullback?

If you are asking yourself whether Limbach Holdings at around US$81.51 is still good value or starting to look expensive, this review is for you. The stock has moved around recently, with a 7 day return of a 16.8% decline, a 30 day return of a 9.1% decline, a 3.1% gain year to date, and an 11.6% gain over the past year. The 3 year return is very large and the 5 year return is also very large. Recent coverage has focused on Limbach as a specialist player in capital goods and building systems,...
NasdaqGS:TTMI
NasdaqGS:TTMIElectronic

Are Volatility and Insider Sales Obscuring TTM Technologies’ (TTMI) AI-Driven Investment Narrative?

In recent days, TTM Technologies has been swept up in a broader technology sector swing, with AI and semiconductor enthusiasm lifting sentiment while geopolitical tensions and higher oil prices briefly weighed on investor confidence. At the same time, insider share sales under a pre-arranged trading plan and the stock’s frequent large price moves underline how sensitive TTM remains to sector news and macro shocks rather than company-specific shifts. With this backdrop of AI-driven optimism...
NasdaqGS:ALAB
NasdaqGS:ALABSemiconductor

Astera Labs Deepens AI Connectivity With Photonics Push And Israel Expansion

Astera Labs agreed to acquire aiXscale Photonics, adding optical and photonics capabilities to its AI connectivity portfolio. The company is launching an Israel Design Center focused on high speed data and AI infrastructure solutions. Astera Labs is expanding ecosystem partnerships, including its role in the UALink consortium and work with major hyperscalers. Astera Labs (NasdaqGS: ALAB) is leaning further into the AI infrastructure theme with a share price of $120.0 and a value score of 1...
NYSE:APG
NYSE:APGConstruction

APi Group Leans On Inspection First Model To Build Cash And Scale

APi Group (NYSE:APG) reports record revenue levels alongside higher profitability. The company highlights 21 consecutive quarters of double digit inspection growth in North America. Management continues to pursue bolt on acquisitions while expanding free cash flow margins. APi Group, listed on the NYSE under the ticker APG, focuses on safety and specialty services with an inspection first model that aims to drive recurring revenue. Recent updates around record revenue, stronger...
NYSE:D
NYSE:DIntegrated Utilities

A Look At Dominion Energy (D) Valuation As Capex Plan And Earnings Momentum Attract Investor Attention

Dominion Energy (D) just paired a larger capital spending plan of US$64.7b for 2026 to 2030 with full year 2025 earnings that show higher sales and net income, catching investors’ attention. See our latest analysis for Dominion Energy. The stronger earnings update and larger capex plan come after a 7.71% 90 day share price return and 22.77% 1 year total shareholder return. This suggests momentum has been building as investors reassess growth and risk in light of new data center contracts. If...
NasdaqGS:ALNY
NasdaqGS:ALNYBiotechs

Is It Time To Revisit Alnylam Pharmaceuticals (ALNY) After Recent Share Price Pullback

Wondering whether Alnylam Pharmaceuticals at around US$320 a share still makes sense for your portfolio, or if the value case has shifted? This article will walk you through what the current price might be implying. The stock has been volatile recently, with a 3.2% decline over the last week, an 8.9% decline over the past month, a 19.9% decline year to date, yet a 29.2% return over 1 year, 72.4% over 3 years, and 124.2% over 5 years. These moves sit against a backdrop of ongoing attention on...
NasdaqGS:DNLI
NasdaqGS:DNLIBiotechs

Denali Therapeutics (DNLI) Is Down 8.0% After Wider Losses And New Shelf Filing Has The Bull Case Changed?

Denali Therapeutics Inc. recently reported fourth-quarter and full-year 2025 results, with net losses of US$128.55 million for the quarter and US$512.54 million for the year, and also filed a US$200.73 million shelf registration for 9,370,929 common shares tied to an ESOP-related offering. Alongside these wider losses and potential equity issuance, Denali is maintaining visibility with investors through a company presentation at TD Cowen’s 46th Annual Health Care Conference held on March 4,...
NasdaqGS:WIX
NasdaqGS:WIXIT

Wix Buyback And AI Shift Raise Questions On Valuation And Risk

Wix.com (NasdaqGS:WIX) has approved a major share repurchase program that includes a large modified Dutch auction tender offer. The company has raised US$250 million through a private placement led by Durable Capital Partners. Wix is accelerating its shift toward AI powered software with the launch of Wix Harmony and the acquisition of Base44. Wix.com, best known for its website building tools, is signaling a new phase as it moves further into broader software applications and AI centric...
NYSE:MOD
NYSE:MODBuilding

Modine Earnings Beat Highlights Data Center Push And Spin Off Plan

Modine Manufacturing (NYSE:MOD) reported Q3 FY2026 results that were ahead of its own expectations. The company raised its full year FY2026 guidance following the quarter. Management highlighted strong growth in Modine's data center related business. Modine announced plans to spin off its Performance Technologies segment into a separate company. Modine Manufacturing focuses on thermal management and engineered solutions across transportation, industrial, and building markets, with data...
NasdaqGS:CAR
NasdaqGS:CARTransportation

Avis Smoke Free Fleet Policy And What It Could Mean For CAR Stock

Avis Budget Group (NasdaqGS:CAR) has imposed a company wide ban on smoking in all North American rental vehicles. The new policy introduces significant penalties for customers who violate the smoke free rules. Avis is the first major rental car company to roll out a blanket smoke free fleet policy at this scale. Health advocacy groups are publicly supporting the move, highlighting its focus on cleaner and healthier vehicles. Avis Budget Group, the parent of Avis and Budget, operates a large...
NasdaqGS:INCY
NasdaqGS:INCYBiotechs

Incyte’s Cash Flow Gains Reshape Earnings Outlook And Capital Return Options

Incyte, ticker NasdaqGS:INCY, is reporting sustained revenue growth alongside an expansion in free cash flow margins. The company is also showing strong earnings momentum, pointing to robust operational performance. These trends highlight an improved ability to invest in the business or return value to shareholders through capital allocation choices. For investors tracking NasdaqGS:INCY, the latest numbers focus attention on how the business is running, not just where the share price sits...
NasdaqGS:AMLX
NasdaqGS:AMLXPharmaceuticals

Amylyx Pharmaceuticals (AMLX) Valuation Check After Improved Results And LUCIDITY Trial Enrollment Completion

Amylyx Pharmaceuticals (AMLX) drew fresh attention after reporting fourth quarter and full year 2025 results that showed smaller losses, while also completing enrollment in its pivotal Phase 3 LUCIDITY trial for avexitide. See our latest analysis for Amylyx Pharmaceuticals. Despite the earnings beat and progress in its pipeline, Amylyx Pharmaceuticals’ recent share price performance has cooled a little, with a 1-day share price return of 6.31% decline and a 7-day share price return of 7.6%...
NasdaqGS:HUBG
NasdaqGS:HUBGLogistics

Hub Group (HUBG) Valuation After $77 Million Accounting Error And Delayed Annual Report

Hub Group (HUBG) has been under pressure after disclosing a $77 million accounting error tied to understated transportation costs and accounts payable. This issue forced delayed 2025 reporting and triggered external investigations into its financial controls. See our latest analysis for Hub Group. The stock has been under pressure recently, with a 1 month share price return of 18.26% decline and a 7 day share price return of 3.95% decline, as investors react to the accounting error, delayed...
NYSE:ASGN
NYSE:ASGNIT

Assessing ASGN (ASGN) Valuation After Recent Share Price Volatility

ASGN (ASGN) has drawn investor attention after recent share price moves, with the stock up 2.8% over the past day but showing weaker performance over the past month and the past 3 months. See our latest analysis for ASGN. That 2.8% 1 day share price gain comes after a tougher stretch, with a 30 day share price return of 15.1% decline and a 1 year total shareholder return of 37% decline. This suggests recent momentum has been fading as investors reassess growth expectations and risk. If ASGN’s...
NYSE:BR
NYSE:BRProfessional Services

Is Broadridge Financial Solutions (BR) Offering Value After Recent Share Price Weakness

If you are wondering whether Broadridge Financial Solutions is reasonably priced or offering value right now, you will want to see how its current share price stacks up against a few different valuation yardsticks. The stock last closed at US$190.89, with returns of 4.2% over the past week and 2.7% over the past month, set against a year to date return of 13.4% decline and a 1 year return of 18.5% decline, while the 3 year and 5 year returns sit at 42.2% and 43.6% respectively. Recent news...
NYSE:WES
NYSE:WESOil and Gas

Is Western Midstream Partners (WES) Pricing Reflect Its Cash Flow And P/E Signals After Recent Gains

If you are looking at Western Midstream Partners and wondering whether the current price reflects its true worth, this article will walk you through the key signals that matter. The units last closed at US$42.19, with returns of 2.5% over the past week, 4.7% over the past month, 6.2% year to date and 22.3% over the last year, plus very large gains over 3 and 5 years that may have changed how investors view its risk and reward profile. Recent news coverage has focused on Western Midstream...
NasdaqGS:ZBRA
NasdaqGS:ZBRAElectronic

Zebra’s New Healthcare Tools And Valuation Gap Set Stage For HIMSS26

Zebra Technologies, NasdaqGS:ZBRA, has introduced its Orchestrated Care framework for healthcare. The company has also launched the DS82-HC Series scanner, focused on clinician workflows and patient safety. Both offerings are scheduled to be showcased at the HIMSS26 conference. Zebra Technologies is expanding its healthcare solutions with Orchestrated Care and the DS82-HC Series, integrating its hardware and software more closely with clinical workflows. The shares last closed at $229.67,...
NYSE:BTU
NYSE:BTUOil and Gas

Is It Too Late To Consider Peabody Energy (BTU) After Its 8x Five-Year Run?

Wondering if Peabody Energy at around US$33.28 is still offering value or if most of the easy gains are behind it? This article walks through what the current price might be implying. The stock has had a mixed short term run, with a 3.1% gain over the last week, a 5.5% decline over the last month, an 8.5% return year to date, and a very large return over the past 5 years that is close to 8x. These moves sit against a backdrop of ongoing attention on coal producers, as investors weigh the...
NYSE:AGX
NYSE:AGXConstruction

Assessing Argan (AGX) Valuation After A Short Term Share Price Pullback

What Argan’s recent share move means for investors Argan (AGX) shares closed at $430.25 after a mixed recent run, with a 7.1% decline over the past day and a 4.9% drop over the past week, despite longer term gains. For investors, that combination of short term weakness and stronger month and past 3 months performance raises a practical question: how does the current price line up with Argan’s fundamentals and recent business trends? See our latest analysis for Argan. Set against a strong...